Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 6


Figure 6 A Comparison of Platelet Reactivity With and Without Eptifibatide

(A) Graph demonstrating mean 5 µmol/l ADP-induced platelet aggregation with and without eptifibatide measured by LTA at baseline, 3 h and 18 to 24 h after percutaneous coronary intervention (PCI). *p < 0.0001 for the change in platelet aggregation in patients receiving eptifibatide versus no eptifibatide. {dagger}p = 0.0004 for platelet aggregation 3 h after PCI in patients receiving eptifibatide versus baseline. (B) Graph demonstrating mean 2 µmol/l ADP-induced platelet aggregation with and without eptifibatide measured by TEG at baseline, 3 h and 18 to 24 h after PCI. *p < 0.0001 for change in platelet aggregation in patients receiving eptifibatide versus no eptifibatide. Abbreviations as in Figure 3.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement